The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

Splintered US-China relations will finally shatter as the enduring trade war escalates. That is what the leading intelligence ...

Based on recent information, the ASEAN LV market is estimated to have dropped by 6% YoY to 3.11 million units in 2024.

The decision was largely viewed as ill-timed as LNG exports were proving to be of strategic importance amid the Ukraine ...

GlobalData predicts rise in data centre investments by cloud providers in 2025, focusing on AI-driven applications and ...

Shoppers took advantage of holiday discounts to snag new clothes and shoes, with many heeding employers’ ongoing calls to ...

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

GlobalData spoke with Paul McGlone, CEO of Seeing Machines, an Australian-based company that produces Driver Monitoring ...